MORE►
Biolabs
GenrAb CEO Larry Tiffany, who is leading the company's push to bring a first-in-class neuroprotective therapy into the clinic, also serves as Executive Chairman and Director at Medcura. [Sources: Medcura photo; iStock background; DI Studio]
UT Southwestern Spinout Emerges From Stealth With $5.6M to Push ‘First in Class’ Neuroprotective Therapy Into the Clinic
by Quincy Preston | Apr 24, 2025
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
by Quincy Preston |
Feb 20, 2025
The new center at Bridge Labs will train the workforce powering North Texas’ biotech boom—helping startups speed therapies, vaccines, and breakthrough biologics from lab bench to patients. Funded in part by Lyda Hill Philanthropies, the National Center for Therapeutics Manufacturing Satellite Campus is set to open this summer.
MORE►
by Quincy Preston |
Oct 15, 2024
Marissa Heyl is rewiring the workplace—with design. Her Inclusive Wellness Design firm uses neuroscience to create joy-inducing, productivity-boosting spaces that give employees another reason to step away from the home office. Think "happy brain chemicals" meets cutting-edge design, with a dash of "Meow Wolf-meets-Miraval" thrown in for good measure.
MORE►
by Quincy Preston |
Aug 29, 2024
At Bisnow's Future of DFW Life Sciences Summit, Davis predicted a "snowball effect" of success in the next three to ten years as the life sciences industry grows. Davis has today's "Last Word."
MORE►
![Clockwise from left: Andrew Denton, Anisha Holla, Ralph Yongoueth, Ananya Sammidi, Asad Moulvi, Sahil Patel, and Rick Tett will pitch in UT Dallas' Big Idea Competition 2024 student and alumni track finals on April 17. [Photos via UT Dallas and the entrepreneurs; Graphics: DI Studio, istockphoto]](https://s24806.pcdn.co/wp-content/uploads/2024/04/UTD-Big-Ideas-Student-Alumni-Track-BIC2024-940x436.jpg)
Clockwise from left: Andrew Denton, Anisha Holla, Ralph Yongoueth, Ananya Sammidi, Asad Moulvi, Sahil Patel, and Rick Tett will pitch in UT Dallas' Big Idea Competition 2024 student and alumni track finals on April 17. [Photos via UT Dallas and the entrepreneurs; Graphics: DI Studio, istockphoto]
UT Dallas’ Big Idea Competition 2024 Expands Its Spotlight On Breakthrough Innovation—And Gives Judges a Larger Role
by Quincy Preston | Apr 4, 2024
The University of Texas at Dallas' largest startup pitch event, now in its 17th year, isn't sitting on its laurels. Here's what's new this year, and who made the finals. With dual events, a fireside chat, and judge-powered prize allocations, it's set to unfold on April 5 and 17.
MORE►
by Quincy Preston and Lance Murray |
Oct 20, 2023
The Advanced Research Projects Agency for Health—or ARPA-H— wants to enable 90% of eligible Americans to participate in clinical trials within 30 minutes of their homes. The agency officially launched its new Texas "customer experience" headquarters at Dallas' Pegasus Park on Thursday, which will be home base for the initiative.
MORE►
by Nicole Ward, DRC Data Journalist |
Feb 22, 2023
The campaign builds on the region's thriving tech sector as the foundation of Dallas-Fort Worth's growing biotech and life science ecosystem. “What we’re seeing now is the cumulative effect of convergence across industries—and that gives DFW an edge," says Mike Rosa, the DRC's economic development chief.
The DRC's new VP of Economic Development, Kelly Cloud, is spearheading efforts to attract startups and established life science companies to Dallas-Fort Worth.
The DRC's new VP of Economic Development, Kelly Cloud, is spearheading efforts to attract startups and established life science companies to Dallas-Fort Worth.
MORE►
by Dallas Innovates | Staff Report |
Nov 1, 2022
The Prix Galien USA Committee honored excellence and innovation in life sciences during the Prix Galien USA Forum and 16th annual Prix Galien Awards Gala last week at the American Museum of Natural History in New York.
One big winner was BioLabs, which has a 37,000-SF coworking and shared wet lab space at the Biotech+ Hub at Pegasus Park in Dallas, along with other locations across the U.S. and in France and Germany.
MORE►
[Graphic: JLL]
JLL’s DFW Life Science Snapshot: What’s Driving the North Texas Biotech Boom
by Lance Murray | Oct 4, 2022
The North Texas biotech boom just keeps booming—and a new "DFW Life Science Snapshot" from JLL shows why. From the Biotech+ Hub at Pegasus Park to a string of accelerators to local universities, DFW Airport, and more, here's a deep dive into what's behind the boom.
"We are showing up in the rankings and in the data," says Mike Rosa of the Dallas Regional Chamber. "It results in more opportunities and more looks for us."
MORE►
by Kevin Cummings |
Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE►
by Kevin Cummings |
Jun 29, 2022
ReCode Therapeutics, a biopharmaceutical startup using a non-viral lipid nanoparticle delivery platform for gene therapies, has closed a $120 million extension to a funding round it raised last year to help bring its lead programs to human trials and “follow the science” to target new diseases.
With a research team working out of BioLabs' life sciences facility at Pegasus Park, ReCode aims to grow its global team from about 70 to 100 over the next year.
MORE►
by Dave Moore |
May 24, 2022
"It takes time" to establish a track record, Jorge Varela says, and the region is starting to see a series of biotech successes and spinoffs that will elevate the region's profile as a biotech hub.
According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
MORE►
![Southwestern Medical Foundation President and CEO Kathleen Gibson has joined the board of nonprofit LaunchBio. [Image: Southwestern Medical Foundation; istockphoto]](https://s24806.pcdn.co/wp-content/uploads/2022/04/Kathleen-Gibson-LaunchBio-board-940x436.jpg)
Southwestern Medical Foundation President and CEO Kathleen Gibson has joined the board of nonprofit LaunchBio. [Image: Southwestern Medical Foundation; istockphoto]
Southwestern Medical Foundation President and CEO Joins LaunchBio Board
by Quincy Preston | Apr 29, 2022
LaunchBio, a life science and biotech nonprofit that expanded to North Texas in 2021, has announced four new board members, including Dallas-based Kathleen Gibson, along with a new board chair.
LaunchBio is working to accelerate the entrepreneurial support network in the region through collaborations with BioLabs, Lyda Hill Philanthropies, J. Small Investments, BioNTX, DLA Piper, and others.
LaunchBio is working to accelerate the entrepreneurial support network in the region through collaborations with BioLabs, Lyda Hill Philanthropies, J. Small Investments, BioNTX, DLA Piper, and others.
MORE►
by Quincy Preston and David Seeley |
Mar 22, 2022
Dallas' status as a growing biotech center got a lift with the official opening of BioLabs, a new coworking space at the Biotech+ Hub at Pegasus Park. The 37,000-square-foot facility offers shared wet labs and office space for up to 35 life science startups.
BioLabs' goal: to serve as the epicenter for life science innovation in North Texas, and to empower biotech trailblazers pursing their next breakthrough.
BioLabs' goal: to serve as the epicenter for life science innovation in North Texas, and to empower biotech trailblazers pursing their next breakthrough.
MORE►
by Kathleen Otto and George Goodno |
Mar 17, 2022
"When it comes to the biotech industry, our region is leading the U.S. in key metrics of job growth and investment," write Kathleen Otto and George Goodno. One proof point? VC funding is flowing into DFW at a faster rate than any other area in the nation.
These North Texas life science leaders say the region's success is no coincidence. Here's how the shared ambition of key players and strategic collaboration has impact.
These North Texas life science leaders say the region's success is no coincidence. Here's how the shared ambition of key players and strategic collaboration has impact.
MORE►
by Dave Moore |
Dec 6, 2021
Mississauga, Ontario-based Evolve Biologics is a producer of plasma-derived therapeutics. The firm's CEO says the new, state-of-the-art, 200,000-SF Sachse facility "will be the foundation of our future growth and global strategy," with the capacity to process 1 million liters of plasma annually and a planned expansion to 2 million liters.
MORE►
